These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25322553)

  • 1. [Gleevec induces apoptosis in K562 cells through activating caspase-3].
    Pu QH; Wu QQ; Jin XB; Wang WZ
    Yao Xue Xue Bao; 2014 Aug; 49(8):1124-9. PubMed ID: 25322553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway.
    Zhang YJ; Lu CR; Cao Y; Luo Y; Bao RF; Yan S; Xue M; Zhu F; Wang Z; Duan LN
    Acta Pharmacol Sin; 2012 Apr; 33(4):551-7. PubMed ID: 22388075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells].
    Chen NY; Wang J; Wang XM; Zhang HX; Yan ZY; Wang YM; Zhang S; Yan B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):882-6. PubMed ID: 20723293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec/Glivec).
    La Rosée P; Shen L; Stoffregen EP; Deininger M; Druker BJ
    Hematol J; 2003; 4(6):413-9. PubMed ID: 14671613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].
    Shi DX; Ma LM; Lu YJ; Bai B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate.
    Jørgensen HG; Allan EK; Mountford JC; Richmond L; Harrison S; Elliott MA; Holyoake TL
    Exp Hematol; 2005 Oct; 33(10):1140-6. PubMed ID: 16219536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells.
    Solmaz S; Adan Gokbulut A; Cincin B; Ozdogu H; Boga C; Cakmakoglu B; Kozanoglu I; Baran Y
    Nutr Cancer; 2014; 66(4):599-612. PubMed ID: 24669768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
    Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytotoxicity of a Grb2-SH3 inhibitor in Bcr-Abl positive K562 cells.
    Ye YB; Lin JY; Chen Q; Liu F; Chen HJ; Li JY; Liu WQ; Garbay C; Vidal M
    Biochem Pharmacol; 2008 Jun; 75(11):2080-91. PubMed ID: 18455151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
    Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
    Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synergistic effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid with imatinib on K562 cells].
    Liu YY; You LS; Qian WB; Tong Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):473-8. PubMed ID: 23086637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
    Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [STI571 induces apoptosis of K562 cells through down-regulation of anti-apoptotic protein Mcl-1 and Bcl-xl expression].
    Zhang BZ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1182-5. PubMed ID: 18088462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].
    Wu RJ; Huang YQ; Ma XD
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ZD6474 on the proliferation of imatinib-resistant K562 cells].
    Jia HY; Wu XM; Wang ZY; Deng XY; Lin Z; Feng GL; Huang WL
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):371-5. PubMed ID: 21122350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells].
    Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.